Who We Are

NewIV is a management, development and commercialization team with deep experience in the field of medical technology.   The management team, Board of Directors and business partners of NewIV represent years of success in finance, development, manufacturing, commercialization, distribution, sales and support in the medical device, critical care and diagnostic markets, with specialized expertise in the infusion pump and home infusion delivery services markets. Our clinical partnerships enable a care provider and patient care focus for the products we deliver.

We are committed to leading NewIV and conducting business with the highest standards of integrity, accountability, and quality. Our Mission is to transform the non-acute care market by bringing first-in-class platform advantages to patients, providers, and payors, for simple, safe, reliable, lower-cost IV therapy with our enabling clinical and operational data services.

Our Leadership Team

Jerry C. Ruddle

Chairman and CEO
As an entrepreneurial med-tech leader, with over 30 years of corporate experience in medical products, Jerry has grown successful breakthrough technology and healthcare service businesses with medical devices, critical care systems, diagnostics, therapeutics and biometrics.

Steven D. Smith

SVP Corporate Development
Senior business development executive with extensive experience leading and building large and small companies. Strategy practice at Booz Allen, senior leader at GE Capital, GE Equity, Ritchie Capital and Pegasus Capital.

David Mulder

Chief Financial Advisor
Dave is a senior executive with more than 25 years of domestic and international experience in finance. With core expertise as a CFO, Dave brings valuable skills to NewIV in M&A, IPOs, SEC reporting, accounting and financial consulting from senior positions at Arthur Anderson, GE Equity, Cigna, Iridian, and Alvarez & Marsal.

Paul Dewey

Vice President, Product Development
With over 30 years of engineering and management experience in med-tech product development and program management, including with the successful Alaris IV infusion pump system, Paul also has a successful track record in hemotherapy, neurology and wireless patient monitoring systems.

Marc Lindahl

Advisor, Engineering
Marc has numerous engineering management, development and regulatory process successes for medical systems companies that include GE, with expertise in system architectures, manufacturability, wireless and embedded processing.

Harriet L. Donnelly

Advisor, Marketing and Communications
A former executive at AT&T and founder and CEO of e5 Marketing, Inc., Harriet and her team bring years of marketing and communications leadership to NewIV, and experience with dozens of US and international corporations and startups. 

Richard Worthen

Advisor, Sales and Strategic Relations
Richard  has over 15 years of experience leading Sales and Marketing teams at Medical Specialties Distributors(MSD) – acquired and now McKesson – the leading distributor of infusion products to the home infusion market, along with his strong leadership successes in companies that include J&J Healthcare and C.R. Bard.

Lise Halpern

Advisor, Business Development
Lise has a strong medical technology and product launch expertise with commercialization successes in executive positions with companies that include Vapotherm, Haemonetics and Transfusion Technologies.

Gregory Zaic

Board Director
A former GM with Baxter Labs Medical Device Division, Greg has 25+ years building successes in the medical products venture capital market, serving on multiple med-tech boards and the Columbia University Ophthalmology Advisory Board.

R. Douglas Hulse

Board Director
The founding CEO of the innovative point-of-care diagnostic i-Stat Corporation, sold to Abbott Labs for approximately $400M, and a founder and Executive Director of the Sage Group, Doug has over 40 years experience building new businesses in the biopharma industry, and is currently CEO of BCI LifeSciences, a prominent advisory firm to biopharma and medical device companies.

Robert Monhan

Board Director
Managing Partner at Triangle HCA. Advised on over $30B in M&A transactions. Former VP of M&A for Walgreens Boots Alliance and Walgreens Infusion, VP M&A Option Care, Director M&A Omnicare; a principal investor at PE firm Lake Capital.

Rod Okamoto

Board Director
Founder and President of Nutrishare, Inc. A pioneer of home infusion pharmacies in the US, and thought leader in the home infusion services market.

Gary A. Gelbfish, M.D.

Board Director
Board certified vascular surgeon; Assistant Professor of Surgery at Mt. Sinai NYC; active vascular surgery physician; experienced med-tech entrepreneur and investor.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt